Dr. Garcia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000Fax+1 206-520-5620
Education & Training
University of WashingtonFellowship, Hematology, 2012 - 2013
Johns Hopkins UniversityResidency, Internal Medicine, 1993 - 1996
University of Alabama School of MedicineClass of 1993
Certifications & Licensure
ID State Medical License 2022 - 2025
WA State Medical License 2012 - 2025
NM State Medical License 1999 - 2015
MD State Medical License 1996 - 2000- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 5 citationsExtending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.Robert D McBane 2nd, Charles L Loprinzi, Tyler Zemla, Alfonso Tafur, Kristen Sanfilippo
Journal of Thrombosis and Haemostasis. 2024-06-01 - 2 citationsDevelopment and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study.Neil A Zakai, Katherine Wilkinson, Andrew D Sparks, Ryan T Packer, Insu Koh
Journal of Thrombosis and Haemostasis. 2024-02-01 - 93 citations2023 ACR/EULAR antiphospholipid syndrome classification criteria.Medha Barbhaiya, Stephane Zuily, Ray Naden, Alison Hendry, Florian Manneville
Annals of the Rheumatic Diseases. 2023-10-01
Abstracts/Posters
- Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated ThrombosisDavid A. Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- D-Dimer As a Prognostic Biomarker for Venous Thromboembolism after Hematopoietic Cell TransplantationDavid A. Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and HyperuricemiaDavid A. Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Long-Term Management of VTE: The First Six Months and Beyond60th American Society of Hematology Annual Meeting - 12/1/2018
- Long-Term Management of VTE: The First Six Months and Beyond60th American Society of Hematology Annual Meeting - 12/1/2018
- Systems-Based Hematology Education and Networking Session60th American Society of Hematology Annual Meeting - 12/1/2018
- Join now to see all
Press Mentions
Blood Clot Busters: 6 Tips to Prevent VTE During Holiday TravelOctober 25th, 2022- No Decrease in DVT Risk with Adjunctive Pneumatic CompressionFebruary 18th, 2020
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
